Skip to main content
Log in

Zweitmalignome nach Strahlentherapie beim Mammarzinom

Einfluss untersucht

  • journal club
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Tubiana M. Radiother Oncol. 2009;91(1):4–15.

    Article  PubMed  Google Scholar 

  2. Berrington de Gonzalez A et al. Int J Radiat Oncol Biol Phys. 2013;86(2):224–33.

    Article  Google Scholar 

  3. Nestle-Krämling C et al. Strahlenther Onkol. 2011;187(10):656–64.

    Article  PubMed  Google Scholar 

  4. Kaufman EL et al. J Clin Oncol. 2008;26(3):392–8.

    Article  PubMed  Google Scholar 

  5. Sautter-Bihl ML et al. Strahlenther Onkol. 2012;188(6):461–3.

    Article  CAS  PubMed  Google Scholar 

  6. Darby S et al. Lancet. 2011;378(9804):1707–16.

    Article  CAS  PubMed  Google Scholar 

  7. Erstpubliziert in Strahlenther Onkol. 2013;189(10):902–3.

Originalie

  • Grantzau T et al. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106(1):42–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marie-Luise Sautter-Bihl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sautter-Bihl, ML., Sedlmayer, F. Zweitmalignome nach Strahlentherapie beim Mammarzinom. Info Onkol. 16, 24–26 (2013). https://doi.org/10.1007/s15004-013-0674-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-013-0674-0

Schlüsselwörter:

Navigation